Immunogenicity for Biopharmaceuticals & Biosimilars Asia 2012
About This Event
Informa Life Sciences has over a decade-long experience in hosting Immunogenicity conferences in the US and Europe and is pleased to present the inaugural Immunogenicity for Biopharmaceuticals & Biosimilars Asia 2012. The ONLY event of its kind in the region, researched with and designed for the community of scientists driving progress and innovation in immunogenicity studies in the region. Bringing you global best practices and case studies, teamed with emerging local knowledge, this event will assist you in formulating solutions to your top immunogenicity challenges.
This comprehensive programme will provide you with a detailed insight to the immunogenicity field, including the underlying causes and implications of immunogenicity, current international developments and best practices in immunogenicity risk assessment, prediction, assay development and regulatory expectations and particular considerations for immunogenicity in the Asian region.
Key discussions across the 2-day programme include:
•Immunogenicity considerations and implications in biosimilar development
•Assessing if there are differences in immunogenic response between the Asian and North European populations and implications in biotherapeutic development
•Successes in reengineering to reduce immunogenicity
•Applying principles learned from immunotherapy to predict and mitigate unwanted immunogenic response